Radiobiological modeling of combined targeted 131I therapy and total body irradiation for treatment of disseminated tumors of differing radiosensitivity
- 1 September 1993
- journal article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 27 (2) , 323-330
- https://doi.org/10.1016/0360-3016(93)90244-p
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- 131I-meta-iodobenzylguanidine therapy in neuroblastoma spheroids of different sizesBritish Journal of Cancer, 1992
- Optimal scheduling of biologically targeted radiotherapy and total body irradiation with bone marrow rescue for the treatment of systemic malignant diseaseInternational Journal of Radiation Oncology*Biology*Physics, 1991
- The curability of tumours of differing size by targeted radiotherapy using 131I or 90YRadiotherapy and Oncology, 1991
- The biodistribution and pharmacokinetics of meta-iodobenzylguanidine in childhood neuroblastomaEuropean Journal of Nuclear Medicine and Molecular Imaging, 1988
- Radiation therapy in the management of neuroblastoma: The Duke University medical center experience 1967–1984International Journal of Radiation Oncology*Biology*Physics, 1986
- Intrinsic radiosensitivity of human cell lines is correlated with radioresponsiveness of human tumors: Analysis of 101 published survival curvesInternational Journal of Radiation Oncology*Biology*Physics, 1985
- The application of the linear-quadratic dose-effect equation to fractionated and protracted radiotherapyThe British Journal of Radiology, 1985